Ligand validation:6SU3

RET: RETINAL

RET is a Ligand Of Interest in 6SU3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SU3_RET_A_818	87%	30%	0.092	0.964	1.6	1.19	4	2	0	0	100%	0.9524
6SU3_RET_X_317	79%	34%	0.112	0.957	1.47	1.13	4	2	0	0	100%	0.9524
6SU4_RET_X_621	86%	36%	0.09	0.96	1.45	1.06	3	1	0	0	100%	0.9524
6UH3_RET_B_301	42%	18%	0.186	0.905	1.7	1.81	5	8	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	10%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	6%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	63%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.